Linda Maxwell's most recent trade in United Therapeutics Corp was a trade of 2,890 Stock Options done . Disclosure was reported to the exchange on July 25, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,890 | 2,890 | - | - | Stock Options | |
ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 77,633 | 77,633 | - | - | Stock Option (right to buy) | |
United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 4,560 | 4,560 | - | - | Stock Options | |
ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 158,263 | 158,263 | - | - | Stock Option (right to buy) | |
United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 4,980 | 4,980 | - | - | Stock Options | |
ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 167,937 | 167,937 | - | - | Stock Option (right to buy) | |
United Therapeutics Corp | Linda Maxwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.44 per share. | 27 May 2022 | 2,000 | 2,000 (0%) | 0% | 102.4 | 204,880 | Common Stock |
United Therapeutics Corp | Linda Maxwell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2022 | 2,000 | 18,680 | - | - | Stock Options | |
United Therapeutics Corp | Linda Maxwell | Director | Sale of securities on an exchange or to another person at price $ 228.00 per share. | 27 May 2022 | 2,000 | 0 (0%) | 0% | 228 | 456,000 | Common Stock |
United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 6,450 | 6,450 | - | - | Stock Options | |
ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 26,064 | 26,064 | - | - | Stock Option (right to buy) | |
ImmunityBio Inc | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 21,873 | 21,873 | - | - | Stock Option (right to buy) | |
United Therapeutics Corp | Linda Maxwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 20,680 | 20,680 | - | - | Stock Options |